about
Association of MHC SNP genotype with susceptibility to type 1 diabetes: a modified survival approachGenetics of type 1 diabetesHLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: analysis of the type 1 diabetes genetics consortium families.Understanding diseases by mouse click: the promise and potential of computational approaches in Systems BiologyWidespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseasesNovel Association Between Immune-Mediated Susceptibility Loci and Persistent Autoantibody Positivity in Type 1 Diabetes.Detection and correction of artefacts in estimation of rare copy number variants and analysis of rare deletions in type 1 diabetes.HLA-DPB1 and HLA class I confer risk of and protection from narcolepsyHLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium familiesNext generation sequencing reveals the association of DRB3*02:02 with type 1 diabetes.Tests for genetic interactions in type 1 diabetes: linkage and stratification analyses of 4,422 affected sib-pairs.Genetics of type 1 diabetes: what's next?Association analysis of SNPs in the IL4R locus with type I diabetes.MHC fine mapping of human type 1 diabetes using the T1DGC data.Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium.Evidence for association of the TCF7 locus with type I diabetes.Association analyses of the vitamin D receptor gene in 1654 families with type I diabetes.Genome-wide association studies: progress and potential for drug discovery and development.Genetic variation within the HLA class III influences T1D susceptibility conferred by high-risk HLA haplotypes.Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypesCollection and processing of whole blood for transformation of peripheral blood mononuclear cells and extraction of DNA: the Type 1 Diabetes Genetics Consortium.Type 1 Diabetes TrialNet--an international collaborative clinical trials networkGenome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes.Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations.Interaction of onset and duration of diabetes on the percent of GAD and IA-2 antibody-positive subjects in the type 1 diabetes genetics consortium database.Predictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 Diabetes Genetics ConsortiumThe effect of the MHC locus on autoantibodies in type 1 diabetesAssociation of RASGRP1 with type 1 diabetes is revealed by combined follow-up of two genome-wide studies.Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 DiabetesNon-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 DiabetesJoint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.Biomarkers for type 1 diabetes.The role of PTPN22 C1858T gene polymorphism in diabetes mellitus type 1: first evaluation in Greek children and adolescentsAnalysis of maternal-offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetesHLA class II genotyping of African American type 1 diabetic patients reveals associations unique to African haplotypes.Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes in the population of South Croatia.Heritability estimates of the Big Five personality traits based on common genetic variants.MHC-environment interactions leading to type 1 diabetes: feasibility of an analysis of HLA DR-DQ alleles in relation to manifestation periods and dates of birth.
P2860
Q24641928-AA1B8204-F2B7-4B97-AD7B-F7D37BAA475AQ26866502-5B450010-C282-4752-A775-E0E7291AC42DQ28397387-1E1E15B0-D4A2-42D8-AB67-FEB6CF7D533DQ28755845-5FB656E8-1C69-42FC-B385-D9F39CFD470CQ30278872-03C3FE39-00C7-494D-993E-23A2E18DCCDBQ30300266-8A189E20-7511-4595-B35A-3AD1E2080B37Q30301272-CC8015EC-77AE-4D7B-AA1A-1588A161050EQ30370632-5BD10C07-293D-43BD-A151-3A31672E7E9AQ30411842-67286BE1-33AD-41A7-B499-CD990C77AA8DQ30412114-97A435DA-2DE8-4559-9C3C-BD2DB8FE28FFQ30428049-74F0C60F-7C29-419A-9CC8-0C84ACD95383Q30431554-60003370-1E27-49FB-89EE-75B3DA092321Q30437311-A6C8FA3C-08CE-46A6-8086-3073304BC45DQ33399893-B75008D6-A89B-46AB-A6A3-C31DE7525CC0Q33517087-14F59EBF-58CD-4375-B4AC-6BCA0A2773F0Q33581627-C00F75AB-0F76-4E84-B149-31C1671A516EQ33588013-B1A0485F-A55A-48F0-8AC3-C2AEF6D355A3Q33784699-598D0A25-FD8E-45DF-BDAE-9BE809417FE6Q33804973-8710F788-238E-4F6B-9A88-9B2DE40C42A7Q34030756-98B6D0FD-5A6E-4BB7-9BCD-A4994F384B15Q34051595-3D585AC3-788D-4058-AC50-9C960191586CQ34055005-5849CE3E-5B5C-43AA-8F2A-5395B31B2266Q34490287-CB4D179B-CD04-4723-A86F-01E2CE0119E5Q34575685-93DFDD2F-5A66-4DBF-A94B-D256F52DD4E3Q34718501-16DBA59A-FE71-4398-86CC-149778922BEFQ35108017-2BCE01E8-23A5-4058-A6C5-999B8D0E8326Q35726979-D17CD73E-11A6-4088-89D6-C67427DC5D53Q35738085-4886319E-93A8-4FC1-86BF-EBD6CD22089DQ36092708-2BFC448C-EE93-4830-AAE3-1D89F0AA2756Q36092713-96AD7DFB-D072-4D7F-ADB9-2A8213DC69AAQ36348307-A60D08BC-30D7-4EE2-A458-CA0353CE02E7Q36608792-68140293-A4E4-4D58-B0C9-FB39421D3C54Q36973929-FB54F739-4D03-44C8-9AB4-BDEDC4AE6A3BQ37000150-80150E95-E7AE-45F8-A268-DA5425C2381EQ37054990-C3A62307-50A8-4E36-96AA-8EAB2A9C3C9EQ37083987-D5CAD24C-ADF3-4F92-AD0A-0994B1BBF0B7Q37110535-C56DBE8E-3D8D-481F-BDB5-F1233C38A434Q37258180-FFFEE9E1-32EB-40CC-8E3C-85DF7F00DA13Q37347560-D5E2FA8E-85D3-42C8-83AF-29036688F20BQ37380925-009B7217-57BC-47F7-9E62-50356ADF9DD9
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The Type 1 Diabetes Genetics Consortium.
@ast
The Type 1 Diabetes Genetics Consortium.
@en
type
label
The Type 1 Diabetes Genetics Consortium.
@ast
The Type 1 Diabetes Genetics Consortium.
@en
prefLabel
The Type 1 Diabetes Genetics Consortium.
@ast
The Type 1 Diabetes Genetics Consortium.
@en
P2093
P2860
P50
P356
P1476
The Type 1 Diabetes Genetics Consortium.
@en
P2093
Cecile Julier
Grant Morahan
Henry Erlich
Jorn Nerup
Stephen S Rich
P2860
P356
10.1196/ANNALS.1375.001
P407
P577
2006-10-01T00:00:00Z